Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Vitelli

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Gut|February 18, 2006
Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearanceA Folgori, E Spada, M Pezzanera, et al.
Vaccine|September 5, 2018
Humoral and cellular immunity to RSV in infants, children and adultsC A Green, C J Sande, C de Lara, et al.
Circulation|December 1, 1998
Enhanced inflammatory response to coronary angioplasty in patients with severe unstable anginaG Liuzzo, A Buffon, L M Biasucci, et al.
BMJ Open|October 30, 2015
Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adultsC A Green, E Scarselli, M Voysey, et al.
Acta Diabetologica|October 18, 2013
A CHO/fibre diet reduces and a MUFA diet increases postprandial lipaemia in type 2 diabetes: no supplementary effects of low-volume physical trainingL Bozzetto, G Annuzzi, G Costabile, et al.
Gut|October 14, 2004
Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearanceE Spada, A Mele, A Berton, et al.
Clinical and Experimental Immunology|January 9, 2023
Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adultsC Green, J McGinley, C Sande, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Gut|February 18, 2006
Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearanceA Folgori, E Spada, M Pezzanera, et al.
Vaccine|September 5, 2018
Humoral and cellular immunity to RSV in infants, children and adultsC A Green, C J Sande, C de Lara, et al.
Circulation|December 1, 1998
Enhanced inflammatory response to coronary angioplasty in patients with severe unstable anginaG Liuzzo, A Buffon, L M Biasucci, et al.
BMJ Open|October 30, 2015
Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adultsC A Green, E Scarselli, M Voysey, et al.
Acta Diabetologica|October 18, 2013
A CHO/fibre diet reduces and a MUFA diet increases postprandial lipaemia in type 2 diabetes: no supplementary effects of low-volume physical trainingL Bozzetto, G Annuzzi, G Costabile, et al.
Gut|October 14, 2004
Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearanceE Spada, A Mele, A Berton, et al.
Clinical and Experimental Immunology|January 9, 2023
Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adultsC Green, J McGinley, C Sande, et al.
Pageof 3